SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-223081
Filing Date
2018-07-23
Accepted
2018-07-23 06:35:41
Documents
13
Period of Report
2018-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d565007d8k.htm 8-K 17298
2 EX-99.1 d565007dex991.htm EX-99.1 13235
3 GRAPHIC g565007ex99_1s10g1.jpg GRAPHIC 207555
4 GRAPHIC g565007ex99_1s11g1.jpg GRAPHIC 128182
5 GRAPHIC g565007ex99_1s1g1.jpg GRAPHIC 183204
6 GRAPHIC g565007ex99_1s2g1.jpg GRAPHIC 625047
7 GRAPHIC g565007ex99_1s3g1.jpg GRAPHIC 279369
8 GRAPHIC g565007ex99_1s4g1.jpg GRAPHIC 384529
9 GRAPHIC g565007ex99_1s5g1.jpg GRAPHIC 339330
10 GRAPHIC g565007ex99_1s6g1.jpg GRAPHIC 278324
11 GRAPHIC g565007ex99_1s7g1.jpg GRAPHIC 264750
12 GRAPHIC g565007ex99_1s8g1.jpg GRAPHIC 381982
13 GRAPHIC g565007ex99_1s9g1.jpg GRAPHIC 249836
  Complete submission text file 0001193125-18-223081.txt   4608900
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

IRS No.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10638 | Film No.: 18963569
SIC: 2834 Pharmaceutical Preparations